Exelixis Inc. (NASDAQ:EXEL) finished Wednesday with a subtraction of -$0.4 to close at $16.50, a downside of -2.37 percent. An average of 2,553,600 shares of common stock have been traded in the last five days. There was a fall of -$0.68 in the past week, and it reached a new high 17 times over the past 12 months. The last 20 days have seen an average of 1,998,455 shares traded, while the 50-day average volume stands at 2,031,232.
EXEL stock has decreased by -13.84% in the last month. The company shares reached their 1-month lowest point of $16.50 on 09/21/22. With the stock rallying to its 52-week high on 04/05/22, shares of the company touched a low of $15.50 and a high of $23.40 in 52 weeks. It has reached a new high 22 times so far this year and lost -9.74% or -$1.78 in price. In spite of this, the price is down -29.49% from the 52-week high.
China Can't Stop US$0.25 Stock from Mining Ultra-Rare Metal
Here's one little-known company — trading undiscovered below 25-cents per share — that's advancing one of the largest and highest quality REE deposits in all of North America... and the Chinese can't do a damn thing about it! It's early stage... and that's excellent news for individual investors like you who have the foresight to act decisively on an emerging megatrend that's already being measured in the Tens of $Billions.
Simply click here and the name & trading symbol are yours.
10 days have passed since Exelixis Inc. (EXEL) last reported insider trading activity. Haley Patrick J., who is EVP, Commercial, most recently acquired $40,000 shares at $17.94 per share on Sep 12. In this transaction, the insider spent $717,600. EVP, Commercial, Haley Patrick J., disposed of 18,812 shares at a price of $18.21 on May 27. The insider now owns more than $342,567 worth of shares. Prior to that, Director WILLSEY LANCE went on to Sale 40,000 shares at $19.65 each on May 12. An amount of $786,000 was transacted.
Exelixis Inc. (EXEL) has a trailing price-to-earnings (P/E) ratio of 19.57. The stock’s beta is 0.66. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 3.41, the price-to-book (PB) ratio at 2.21, and the price-to-cash flow ratio at 17.10.
The quick ratio of Exelixis Inc. for the three months ended June 29 was 6.00, and the current ratio was 6.10, indicating that the company is able to meet its debt obligations. Further, the company has a long term debt to equity ratio of 0.00 and a total debt to equity ratio of 0.00 for the quarter ending June 29. Its gross profit as reported stood at $1.38 billion compared to revenue of $1.43 billion.
For investors, determining the potential profitability of the investment also depends on the performance of the company’s management. In the past 12 months, Exelixis Inc.’s return on assets was 10.30%.
For the three-month period that ended June 29, Exelixis Inc. had $907.94 million in cash. In the quarter under review, the net income was up than the previous quarter. The company posted a net income of $70.67 million in the quarter, while revenues of $68.57 million were shrunk -35.97%. The analyst consensus anticipated Exelixis Inc.’s latest quarter earnings to come in at $0.19 per share, but it turned out to be $0.22, a 15.80% surprise. For the quarter, EBITDA amounted to $88.48 million. Shareholders own equity worth $321.83 million.
From a technical analysis perspective, let’s take a brief look at Exelixis Inc. (EXEL) price momentum. RSI 9-day as of the close on 21 September was 19.96%, suggesting the stock is oversold, with historical volatility in this time frame at 24.98%.
As of today, EXEL’s price is $16.92 -3.96% or -$0.68 from its 5-day moving average. EXEL is currently trading -13.66% lower than its 20-day SMA and -27.54% lower than its 100-day SMA. However, the stock’s current price level is -21.69% below the SMA50 and +4.17% above the SMA200.
The stochastic %K and %D were 16.28% and 15.21%, respectively, and the average true range (ATR) was 0.48. With the 14-day stochastic at 0.00% and the average true range at 0.51, the RSI (14) stands at 24.87%. The stock has reached -0.43 on the 9-day MACD Oscillator while the 14-day reading was at -0.65.
BMO Capital Markets launched coverage on Exelixis Inc. (NASDAQ: EXEL) in its analyst report released on June 24, 2022. The firm assigned the stock an Outperform rating.